Ergebnisse für *

Zeige Ergebnisse 1 bis 1 von 1.

1. Some policy lessons from medical/therapeutic responses to the COVID-19 crisis: a rich research system for knowledge generation and dysfunctional institutions for its exploitation

   Autor*in: Dosi, Giovanni

   Erschienen: [2021]

   Verlag:  LEM, Laboratory of Economics and Management, Institute of Economics, Scuola Superiore Sant'Anna, Pisa, Italy

   This note discusses the medical/therapeutical responses to the COVID-19 pandemic and their “political economy” context. First, the very quick development of several vaccines highlights the richness of the basic knowledge waiting for therapeutical... mehr

   • Bibliographische Angaben
   • Zugang
   • Beschreibung
   • Export

   Zugang:

   Verlag (kostenfrei) Verlag (kostenfrei) Resolving-System (kostenfrei)

   Kiel: ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel

   Standort:

   ZBW - Leibniz-Informationszentrum Wirtschaft, Standort Kiel

   Signatur:

   DS 203

   Fernleihe:

   keine Fernleihe

   This note discusses the medical/therapeutical responses to the COVID-19 pandemic and their “political economy” context. First, the very quick development of several vaccines highlights the richness of the basic knowledge waiting for therapeutical exploitation. Such knowledge has largely originated in public or non-profit institutions. Second, symmetrically, there is longer-term evidence that the private sector (essentially Big Pharma) has decreased its investment in basic research in general, and has long been uninterested in vaccines in particular. Only when flooded with an enormous amount of public money it became eager to undertake applied research, production scale-up and testing. Third, the “political economy” of the underlying public-private relationship reveals a profound dysfunctionality with the public being unable to determine the rates and direction of innovation, but at the same time confined to the role of payer of first and last resort, with dire consequences for both advanced, and more so, developing countries. Fourth, on normative grounds, measures like ad hoc patent waivers are certainly welcome, but this will not address the fundamental challenge, involving a deep reform of the Intellectual Property Rights regimes and their international protection (TRIPS Agreements).

   Export in Literaturverwaltung

   RIS-Format   BibTeX-Format

   Quelle:	Verbundkataloge
   Sprache:	Englisch
   Medientyp:	Buch (Monographie)
   Format:	Online
   Weitere Identifier:	hdl: 10419/243515
   Schriftenreihe:	LEM working paper series ; 2021, 19 (May 2021)
   Schlagworte:	Covid-19 pandemic; vaccines; Intellectual property rights; TRPS; innovation; public goods
   Umfang:	1 Online-Ressource (circa 14 Seiten)